Evidence mapPaperPMID 41510171Full record

ArticleTheranostics2026

Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery.

Laxman Subedi, In Ho Im, Arjun Dhwoj Bamjan, Jiwon Jeon, Susmita Phuyal, Yun-Hwa Jeong, Seung Hyun Kim, Jung-Hyun Shim, Jeong Uk Choi, Jin Woo Park

Abstract read
In one paragraph

Article in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laxman SubediDepartment of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.
In Ho ImDepartment of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Arjun Dhwoj BamjanDepartment of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.
Jiwon JeonDepartment of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Susmita PhuyalDepartment of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.
Yun-Hwa JeongDepartment of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Seung Hyun KimDepartment of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Jung-Hyun ShimDepartment of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.
Jeong Uk ChoiDepartment of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Jin Woo ParkDepartment of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FerroptosisNanoparticlesTriple Negative Breast NeoplasmsAdministration, MetronomicAdministration, OralAnimalsAntineoplastic AgentsCell Line, TumorDrug Delivery SystemsFemaleHumansLipidsMiceTumor MicroenvironmentAntineoplastic AgentsLipidscombination chemotherapyferroptosisimmune modulationmetronomic low-dose regimenmultimodal transporter-facilitated absorptionoral nanoplatform

Identifiers

PMID41510171
PMCPMC12775813

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.